Papers

9

Total Citations

285

H-Index

5

About

Markus K. Diener is a leading surgical researcher whose work centers on advancing minimally invasive techniques for complex gastrointestinal and pancreatic surgeries. His major contributions lie in rigorously evaluating robotic and laparoscopic approaches against traditional open procedures through high-impact randomized controlled trials. Diener is best known for his leadership of the EUROPA trial, a landmark stage 2b randomized study comparing robotic versus open partial pancreatoduodenectomy, which has already garnered 118 citations and is reshaping surgical standards for pancreatic head diseases. He has also conducted influential systematic reviews, including a network meta-analysis on adrenalectomy approaches (105 citations), and has designed multiple pivotal trial protocols such as DISPACT-2 for distal pancreatectomy and the MICkey trial for minimally invasive esophagectomy. His work consistently focuses on reducing postoperative morbidity—a key challenge in pancreatic and esophageal surgery—while maintaining oncologic safety. With a portfolio of over 250 citations across his most-cited papers, Diener is a driving force in evidence-based surgical innovation, helping to define the future of minimally invasive oncologic surgery.

Research Focus

Key Achievements

5
H-Index
9
Papers
285
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial
118 citations · 2024
📈 Most Prolific Year: 2021 (3 Papers)
🤝 Key Collaborators: 55
🏛 Institutions: Heidelberg University, German Society of Surgery, University Medical Center Freiburg, Paracelsus Medical University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago